-- 
SWISS DAYBOOK: Roche Agrees to Buy Anadys, UBS, Kuehne & Nagel

-- B y   C o r i n n e   G r e t l e r   a n d   E l e n a   L o g u t e n k o v a
-- 
2011-10-17T05:48:17Z

-- http://www.bloomberg.com/news/2011-10-17/swiss-daybook-roche-agrees-to-buy-anadys-ubs-kuehne-nagel.html
Roche Holding AG (ROG)  said it agreed to
buy Anadys Pharmaceuticals Inc. for about $230 million to expand
its portfolio of drugs to treat hepatitis C infection.  Anadys’s most advanced drug candidate is a direct-acting
antiviral compound that’s being evaluated by the  San Diego ,
California-based company in a phase II study in combination with
Roche’s pegylated interferon and ribavirin, Basel-based Roche
said.  EQUITIES:
*Kuehne & Nagel third-quarter net income fell 16 percent to 142
million Swiss francs
* Temenos Group AG (TEMN)  raised to “hold” from “sell” at
Deutsche Bank
*UBS remains committed to  investment banking  and the group may
need about two to four years to recover, interim CEO Ermotti
told SonntagsBlick
*UBS Honorary Chairman Nikolaus Senn said Kaspar Villiger should
resign early, SonntagsZeitung reported
*Swiss Raiffeisen group CEO Vincenz favors longer-term merger of
Sarasin and Vontobel, SonntagsZeitung reported
*Sarasin, Raiffeisen and Rabobank have been in talks in the past
two weeks over an agreement under which Raiffeisen would acquire
33 percent of Rabobank’s voting shares in Sarasin,
SonntagsZeitung said, citing unidentified insiders  MARKETS:
*The benchmark SMI climbed 0.8 percent to 5,761.12
*The SPI rose 0.9 percent to 5,214.56
*The Stoxx Europe 600 Index increased 0.8 percent to 238.51 *The
MSCI Asia-Pacific Index rose 1.8 percent at 7:40 a.m. Zurich
time
*Euro-franc traded at 1.23816 at 7:41 a.m. Swiss time  To contact the reporter on this story:
Corinne Gretler in Zurich at 
 cgretler1@bloomberg.net   To contact the editor responsible for this story:
Matthias Wabl at 
 mwabl@bloomberg.net  